PartnershipUpdated on 10 November 2025
Seeking Partners in Space Biotech & Oncology Research
Co-Founder, COO at SPARK Microgravity GmbH
Munich, Germany
About
SPARK Microgravity is developing a modular, autonomous platform for studying cancer cells in true microgravity. Our payload will launch in Q1 2026.
We are actively seeking partners in:
-
Pharma & biotech for joint pre-clinical oncology research and drug discovery validation in orbit.
-
Launch providers (microlaunchers, LEO platforms, sounding rockets) for recurring access to space within Europe.
-
Academic and research institutions for collaborative studies and data analysis in 3D cancer biology.
SPARK aims to build a long-term European ecosystem connecting life science, space hardware, and translational research. Let’s make space biology work for patients on Earth.
Organisation
Similar opportunities
Investment
Invest in SPARK Microgravity: Building the Orbital Cancer Lab
Katharina Weidmann
Co-Founder, COO at SPARK Microgravity GmbH
Munich, Germany
Project cooperation
Space-Enabled Cancer Research & Bioreactor Technologies
Katharina Weidmann
Co-Founder, COO at SPARK Microgravity GmbH
Munich, Germany
Service
- Space
- Equipment
- Space technology
- Space exploration
- Engineering service
- Research & Development
- Production and process technologies
- Measurement, testing, proofing, diagnostic systems
Maxime Goffinet
Communications & Media Coordinator at Space Applications Services
Belgium